Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duesbery

Showing results (41-50 of 68) with videos related to

Pageof 7
Sort By:
Current Pharmaceutical Design|October 14, 2003
Novel protein targeted therapy of metastatic melanomaArthur E Frankel, Han-Mo Koo, Stephen H Leppla, et al.
Developmental Biology|May 26, 2005
Differential roles of p39Mos-Xp42Mpk1 cascade proteins on Raf1 phosphorylation and spindle morphogenesis in Xenopus oocytesJ-F L Bodart, F Y Baert, C Sellier, et al.
Molecular Cancer Therapeutics|September 20, 2005
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxinRalph J Abi-Habib, Jeffrey O Urieto, Shihui Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinaseHan-Mo Koo, Matt VanBrocklin, Mary Jane McWilliams, et al.
The EMBO Journal|November 1, 2003
Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25CEusebio Perdiguero, Marie-Jeanne Pillaire, Jean-Francois Bodart, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2001
Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathwaysN S Duesbery, J Resau, C P Webb, et al.
Developmental Biology|April 30, 2002
Characterization of MPF and MAPK activities during meiotic maturation of Xenopus tropicalis oocytesJean-Francois L Bodart, Davina V Gutierrez, Angel R Nebreda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude miceRalph J Abi-Habib, Ravibhushan Singh, Stephen H Leppla, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 1997
CENP-E is an essential kinetochore motor in maturing oocytes and is masked during mos-dependent, cell cycle arrest at metaphase IIN S Duesbery, T Choi, K D Brown, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Pathophysiology of anthraxArthur E Frankel, Shu-Ru Kuo, David Dostal, et al.
Pageof 7

Showing results (41-50 of 68) with videos related to

Sort By:
Pageof 7
Current Pharmaceutical Design|October 14, 2003
Novel protein targeted therapy of metastatic melanomaArthur E Frankel, Han-Mo Koo, Stephen H Leppla, et al.
Developmental Biology|May 26, 2005
Differential roles of p39Mos-Xp42Mpk1 cascade proteins on Raf1 phosphorylation and spindle morphogenesis in Xenopus oocytesJ-F L Bodart, F Y Baert, C Sellier, et al.
Molecular Cancer Therapeutics|September 20, 2005
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxinRalph J Abi-Habib, Jeffrey O Urieto, Shihui Liu, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2002
Apoptosis and melanogenesis in human melanoma cells induced by anthrax lethal factor inactivation of mitogen-activated protein kinase kinaseHan-Mo Koo, Matt VanBrocklin, Mary Jane McWilliams, et al.
The EMBO Journal|November 1, 2003
Xp38gamma/SAPK3 promotes meiotic G(2)/M transition in Xenopus oocytes and activates Cdc25CEusebio Perdiguero, Marie-Jeanne Pillaire, Jean-Francois Bodart, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 22, 2001
Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathwaysN S Duesbery, J Resau, C P Webb, et al.
Developmental Biology|April 30, 2002
Characterization of MPF and MAPK activities during meiotic maturation of Xenopus tropicalis oocytesJean-Francois L Bodart, Davina V Gutierrez, Angel R Nebreda, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Systemic anthrax lethal toxin therapy produces regressions of subcutaneous human melanoma tumors in athymic nude miceRalph J Abi-Habib, Ravibhushan Singh, Stephen H Leppla, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 19, 1997
CENP-E is an essential kinetochore motor in maturing oocytes and is masked during mos-dependent, cell cycle arrest at metaphase IIN S Duesbery, T Choi, K D Brown, et al.
Frontiers in Bioscience (Landmark Edition)|March 11, 2009
Pathophysiology of anthraxArthur E Frankel, Shu-Ru Kuo, David Dostal, et al.
Pageof 7